Revivocell Inc.
NY
- UEI
- R7EYRQWWQHU5
- CAGE
- 9YW63
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 4345 Webster Ave #5i, Bronx, NY 10470, USA
- Website
- revivocell.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
SBA capabilities narrative
Revivocell Inc. develops next-generation human-relevant microphysiological systems (MPS) for drug discovery, safety, and efficacy testing. Using its patented NANOSTACKS and CELLBLOKS platforms, Revivocell recreates complex multicellular human organ and multi-organ models that incorporate physiological flow, immune competence, and AI-driven analytics. These animal-free systems enable predictive modeling of disease and drug response in liver, brain, and barrier tissues, supporting FDA Modernization Act 2.0 and Next-Generation Risk Assessment (NGRA) initiatives. The company's PhD-level team integrates tissue engineering, stem-cell biology, and data science to deliver validated, reproducible models that accelerate translational innovation for government, pharmaceutical, and academic partners.
Quick answers
Is Revivocell Inc. registered in SAM.gov?
Yes. Revivocell Inc.'s SAM.gov registration is active through September 25, 2027.
On GovTribe
See Revivocell Inc.'s full federal record
- Similar vendors